Acute trust takes over treatment centre after £53m pay off to private companyBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4955 (Published 06 August 2013) Cite this as: BMJ 2013;347:f4955
- Chris Mahony
An “undesirable” payment of £53m (€61m; $81m) to a private company to withdraw from an underperforming independent sector treatment centre (ISTC) highlights the risk of commercial organisations winning NHS contracts, the BMA has said.
Clinicenta, which is owned by property support services company Carillion, will be paid £53m to hand over the Lister surgicentre in Stevenage to East and North Hertfordshire NHS Trust, the local acute trust where it is sited.
The bulk of the money, £46m, represents the cost of purchasing the building and equipment but the deal includes £3m compensation to the company for ending the contract early. An additional £4m …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial